eGenesis names new CFO and CCO as clinical programs advance

Go back to eGenesis names new CFO and CCO as clinical programs advance
(NASDAQ: EVAX) Delayed: 3.39 -0.03 (0.88%)
Previous Close $3.42    52 Week High
Open $3.40    52 Week Low
Day High $3.60    P/E N/A 
Day Low $3.38    EPS
Volume 11,474